News

United States News

Grafa

Breaking News

Grafa

Security software stocks face a fresh profit test

  • BlackBerry reported Q1 FY2027 revenue of $152.9 million, up 26% year over year, with adjusted EBITDA of $36.3 million and GAAP operating income of $15.3 million.
  • The comparison group shows a wide revenue gap, from Cerence’s $64.2 million quarterly revenue to Palo Alto Networks’ $3 billion quarterly revenue.
  • The main sector test is whether AI security, connected-vehicle software, and government communications can keep growing while margins stay under control.
Read more
Grafa
Tech

How escalating artificial intelligence hardware demand is rewriting memory chip valuations

  • Micron Technology reported $41.46 billion in quarterly revenue as the firm capitalized on surging data center component demand.
  • The semiconductor manufacturer recorded a GAAP net income of $28.24 billion and declared a quarterly dividend of $0.15 per share.
  • Global hardware manufacturers must carefully secure raw materials to execute aggressive revenue projections amid volatile enterprise capital expenditures.
Read more
How escalating artificial intelligence hardware demand is rewriting memory chip valuations
Grafa

How global delivery networks are quietly sacrificing scale to protect operational margins

  • FedEx reported $25 billion in fourth-quarter fiscal 2026 revenue while executing a spin-off of its freight division to consolidate core operations.
  • The logistics provider exceeded cost-cutting targets by securing over $1 billion in structural savings and achieving an adjusted earnings per share of $6.60.
  • Global transportation firms face mounting pressure to offset mixed profitability trends by heavily reducing capital spending and divesting secondary business units.
Read more
How global delivery networks are quietly sacrificing scale to protect operational margins
Grafa

Why dominant pharmaceutical firms are paying billion-dollar premiums for immunology assets

  • AbbVie agreed to acquire Apogee Therapeutics in a $10.9 billion all-cash transaction, paying a 60% premium to secure a late-stage immunology pipeline.
  • The company will pay $135.11 per share, with executives projecting the deal will not become accretive to adjusted earnings until 2032.
  • Large pharmaceutical manufacturers face intense capital pressure to acquire unproven, long-acting biologics to offset impending revenue losses from patent expirations.
Read more
Why dominant pharmaceutical firms are paying billion-dollar premiums for immunology assets

Insights

Grafa

The unintended green revolution

For decades, the global transition to renewable energy was a project of incrementalism — a slow-moving mosaic of carbon taxes, solar subsidies, and earnest international accords that often felt more aspirational than urgent. 

Policy wonks argued over the nuances of the Inflation Reduction Act, while climate activists lamented the glacial pace of the "energy pivot."

Read more
The unintended green revolution
Grafa

The Boomer gold rock is back

For the better part of a decade, the gilded youth of the financial world — the "crypto-native" generation — dismissed gold as a "boomer rock." 

To them, the heavy, yellow metal was an analog relic, a petrous souvenir of an era before the lightning-fast efficiency of the blockchain. 

Read more
The Boomer gold rock is back
Grafa

The bull market in bloodshed

For years, the global defence industry existed in a sort of polite exile. 

In the era of ESG mandates and the "peace dividend," shares in weapons manufacturers were often treated as the "tobacco stocks" of the new millennium — profitable, perhaps, but unseemly. 

Read more
The bull market in bloodshed

Economy

Grafa
Economy

Markets brace for Tuesday deadline as Trump threatens Iranian power grid

Global financial markets entered a state of high-alert Monday morning as President Donald Trump issued a final, televised ultimatum to Tehran, threatening the total destruction of Iran’s industrial infrastructure if the Strait of Hormuz is not reopened by Tuesday evening.

Read more
Markets brace for Tuesday deadline as Trump threatens Iranian power grid
Grafa
Economy

U.S. job growth beats forecasts in March amid escalating geopolitical risks

U.S. hiring rebounded more sharply than anticipated in March as the return of striking healthcare workers and seasonal warming bolstered payrolls, providing a temporary reprieve for a labor market increasingly clouded by Middle East conflict and trade volatility.

Read more
U.S. job growth beats forecasts in March amid escalating geopolitical risks

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.